Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fate Therapeutics makes two appointments, one promotion

This article was originally published in Scrip

Executive Summary

Fate Therapeutics, a biopharmaceutical company developing cellular therapeutics for the treatment of life-threatening diseases, has named Dr Wendy Levin vice-president of clinical development and Walter Grubb vice-president of business development. Dr Levin, a board-certified hematologist/oncologist, joins Fate from MEI Pharma, where she was vice-president of clinical development and medical affairs. Mr Grubb was previously executive director of business development and commercial operations at Ambit Biosciences.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts